18F-JK-PSMA-15

N/A

Report date: 2025/11/21 17:15:27

NME

Base Information

Drug Name18F-JK-PSMA-15

Drug Alias Name[18F]JK-PSMA-1518-F-JK-PSMA-15

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesForschungszentrum Jülich GmbH

China Registration ClassN/A

Develop Information

Active CompaniesForschungszentrum Jülich GmbH

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A